Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR

• Autorzy: Kilic A , Onguru O. , Tugcu H. , Kilic S. , Guney C. , Bilge Y.
• Języki publikacji: EN

Abstrakty

EN

It has been suggested that some microorganisms may play a role in the etiology or progression of atherosclerotic plaques. The purpose of this study was to assess for the presence of Helicobacter pylori and cytomegalovirus (CMV) DNA using polymerase chain reaction (PCR) technique in vascular-wall specimens obtained during autopsy. Four to 5 mm long samples from 3 different vascular wall specimens (coronary, carotid and abdominal aortas) of 30 patients (23 male, 7 female) were taken for pathologic and microbiologic investigations during autopsy. H. pylori DNA was found in 48.2% atherosclerotic and 19.6% non-atherosclerotic vascular wall specimens, whereas CMV DNA was found in 37.9% atherosclerotic and 32.7% non-atherosclerotic vascular wall specimens. In terms of CMV DNA detection, no statistically significant differences between the atherosclerotic and non-atherosclerotic groups were present (P>0.05). However, there was a statistically significant difference between the atherosclerosis and non-atherosclerotic groups in terms of H. pylori DNA in coronary and abdominal aorta arteries (p = 0.016 and p = 0.0029 respectively) but not in carotid arteries (p= 1.00). In conclusion, the correlation between H. pylori and atherosclerosis could be suggested. These finding warrant further investigation regarding the role of H. pylori in atherosclerosis.

Słowa kluczowe

EN

arterial wall; human disease; risk factor; cytomegalovirus; DNA; grade III atherosclerosis; detection; Helicobacter pylori; atherosclerosis

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2006
• Tom: 55
• Numer: 4
• Opis fizyczny: p.333-337,fig.,ref.

Twórcy

autor

Kilic A

• Gulhane Military Medical Academy, School of Medicine, 06018 Ankara, Turkey

autor

Onguru O.

autor

Tugcu H.

autor

Kilic S.

autor

Guney C.

autor

Bilge Y.

Bibliografia

• Ameriso S.F., E.A. Fridman, R.C. Leiguarda and G.E. Sevlever. 2001. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32: 385-391.
• Blasi F., M.L. Ranz i, M. Erba, R Tarsia, R. Raccanelli, L. Fagetti and L. Allegra. 1996. No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. Atherosclerosis 126: 339-340.
• Bioemenkamp D.G., W.R Mali, B.C. Tanis, F.R. Rosendaal, M.A. van den Bosch, J.M. Kemmeren, A. A Igra, J.M. Ossewaarde, F.L. Visseren, A.M. van der Loon and Y. Graaf. 2002. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis 163: 149-156.
• Carlsson J., S. Miketic, J. Brom, R. Ross, H. Bachmann and U. Tebbe. 2000. Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty. Int. J. Cardiol. 73: 165-171.
• Chiu B., E. Viira, W. Tucker and I.W. Fong. 1997. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96: 2144-2148.
• Danesh J., J. Koreth, L. Young man, R. Collins, J.R. Arnold, Y. Balarajan, J. McGee and D. Roskell. 1999. Is Helicobacter pylori a factor in coronary atherosclerosis? J. Clin. Microbiol. 37:1651.
• Fabricant CG., J. Fabrican t, M.M. Litrenta and CR. Minick. 1978. Virus-induced atherosclerosis. J. Exp. Med. 148: 335-340.
• Farsak B., A. Yildirir, Y. Akyon, A. Pinar, M. Oc, E. Boke, S. Kes and L. Tokgozoglu. 2000. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J. Clin. Microbiol. 38: 4408-4411.
• Grahame-Clarke C, N.N. Chan, D. Andrew, G.L. Ridgway, D.J. Betteridge, V. Emery, H.M. Colhoun and P. Vallance. 2003. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108: 678-683.
• Gupta S., E.W. Leatham, D. Carrington, M.A. Mendall, J.C. Kaski and A.J. Camm. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96: 404-407.
• Hendrix M.G.R., M.M.M. Salimans, C.RA. van Boven and C.A. Bruggeman. 1990. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136: 23-28.
• Hendrix M.G., M. Daemen and C.A. Bruggeman. 1991. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 138: 563-567.
• Heuschmann P.U., D. Neureiter, M. Gesslein, B. Craiovan, M. Maass, G. Faller, G. Beck, Neundoerfer and P.L. Kolominsky-Rabas. 2001. Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study. Stroke 32: 2253-2258.
• Ho Y.W., K.Y Ho, F. Ascencio and B. Ho. 2004. Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes. World J. Gastroenterol. 10:3274-3277.
• Horne B.D., J.B. Muhlestein, J.F. Carlquist, T.L. Bair, T.E. Madsen, N.L. Hart and J.L. Anderson. Inter-mountain Heart Collaborative (IHC) Study Group. 2003. Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease. Circulation 107: 258-263
• Libby P., D. Egan and S. Skarlatos. 1997. Role of infectious agents in atherosclerosis and restenosis. An assessment of the evidence and need for future research. Circulation 96: 4095-4103.
• Maass M., C. Bartels, P.M. Engel, U. Mamat and H.H. Sievers. 1998. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J. Am. Coll. Cardiol. 31: 827-832.
• Melnick J.L., C. Hu, J. Burek, El Adam and M.E. Debakey. 1994. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:170-174.
• Nieto F.J., E. Adam, P. Sorlie, H. Farzadegan, J.L. Melnick, G.W. Comstock and M. Szklo. 1996. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 94: 922-927.
• Pasceri V., G. Cammarota, G. Patti, L. Cuoco, A. Gasbarrini, R.L. Grillo, G. Fedeli, G. Gasbarrini and A. Maseri. 1998. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 97: 1675-1679.
• Patel P., M.A. Mendall, D. Carrington, D.P Strachan, E. Leatham, N. Molineaux, J. Levy, C. Blakeston, C.A. Seymour, A.J. Camm and T.C. North fie Id. 1995. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Brit. Med. J. 311: 711-714.
• Porsch-Ozcurumez M., W. Doppl, PD. Hardt, H. Schnell-Kretschmer, M. Tuncay, A. Akinci, Y. Bilgin and H.U. Klor. 2003. Impact of migration on Helicobacter pylori seroprevalence in the offspring of Turkish immigrants in Germany. Turk. J. Pediatr. 45: 203-208.
• Rechciński T., A. Grębowska, M. Kurpesa, W. Rudnicka, M. Krzemińska-Pakula and M. Chmiela. 2005. Occurrence of serum class G immunoglobulins interacting with specific antigens of Helicobacter pylori in patients with unstable coronary artery disease and in symptomless individuals. Pol. J. Microbiol. 54: 221-225.
• Regnstrom J., S. Jovinge, P. Bavenholm, C.G. Ericsson, U. De Faire, A. Hamsten, M.L. Hellenius, J. Nilsson and P. Tornvall. 1998. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J. Intern. Med. 243: 109-113.
• Reinhardt B., R. Minisini and T. Mertens. 2002. Opinion article: cytomegalovirus is a risk factor in atherogenesis. Herpes 9: 21-23.
• Reinhardt B., B. Vaida, R. Voisard, L. Keller, J. Breul, H. Metzger, T. Herter, R. Baur, A. Luske and T. Mertens. 2003. Human cytomegalovirus infection in human renal arteries in vitro. J. Virol. Methods. 109: 1-9.
• Ridker P.M., C.H. Hennekens, J.E. Buring, R. Kundsin and J. Shih. 1999. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, Herpes simplex virus, and Cytomegalovirus and the risk for cardiovascular disease in women. Ann. Intern. Med. 131: 573-577.
• Roivainen M., M. Viik-Kajander, T. Palosuo, P. Toivanen, M. Leinonen, P. Saikku, L. Tenkanen, V. Manninen, T. Hovi and M. Manttari. 2000. Infections, inflammation, and the risk of coronary heart disease. Circulation 101: 252-257.
• Saygun L, M. Yapar, A. Ozdemir, A. Kubar and J. Slots. 2004. Human cytomegalovirus and Epstein-Barr virus type 1 in periodontal abscesses. Oral. Microbiol. Immunol. 19: 83-87.
• Sinha S.K., B. Martin, M. Sargent, LP McConnell and C.N. Bernstein. 2002. Age at acquisition of Helicobacter pylori in a pediatric Canadian First Nations population. Helicobacter 7: 76-85.
• Siscovick D.S., S.M. Schwartz, L. Corey, J.T. Grayston, R. Ashley, S.P Wang, B.M. Psaty, R.P Tracy, L.H. Kuller and R.A. Kronmal. 2000. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the cardiovascular health study. Circulation 102: 2335-2340.
• Stary H.C., A.B. Chandler, R.E. Dins more, V. Fuster, S. Glagov, W.Jr. Insult, M.E. Rosenfeld, J. Schwartz, W.D. Wagner and R.W. Wissler. 1995. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355-1374.
• Takashima T., K. Adachi, A. Kawamura, M. Yuki, H. Fujishiro, M.A. Rumi, S. Ishihara, M. Watanabe and Y. Kinoshita. 2002. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter 7: 86-90.